Stay updated on Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.

Latest updates to the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page
- Check2 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check9 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe study page now redirects to a 403 Forbidden error screen, indicating restricted access to the content. The error page shows the site header/footer but no study details.SummaryDifference18%

- Check44 days agoChange DetectedThe metadata section loses the 'Melanoma' tag and related topic links (MedlinePlus Genetics), removing cross-links to related resources while leaving the main study information unchanged.SummaryDifference0.2%

- Check52 days agoChange DetectedAdded related topics: Melanoma and MedlinePlus Genetics, and updated the revision tag from v3.6.5 to v3.6.6.SummaryDifference0.2%

- Check59 days agoChange DetectedThe related topics/MeSH terms section was updated to remove Melanoma and MedlinePlus Genetics, narrowing the disease and genetics topics tied to this study. This change impacts how the study is indexed and discovered rather than altering the study details shown to users.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.